Edition:
United States

ALK-Abello A/S (ALKb.CO)

ALKb.CO on Copenhagen Stock Exchange

1,018.00DKK
18 May 2018
Change (% chg)

kr.10.00 (+0.99%)
Prev Close
kr.1,008.00
Open
kr.1,006.00
Day's High
kr.1,022.00
Day's Low
kr.1,002.00
Volume
29,531
Avg. Vol
20,768
52-wk High
kr.1,081.00
52-wk Low
kr.646.00

Select another date:

Tue, Feb 6 2018

BRIEF-ALK-Abello Q4 EBITDA Falls To DKK 61 Million

* Q4 TOTAL REVENUE DKK ‍763​ MILLION (REUTERS POLL: DKK 771 MILLION)

BRIEF-ALK-Abello Provides Pricing In New Share Issue

* PRESS RELEASE PRICING AND FURTHER DETAILS ON THE OFFERING OF NEW SHARES IN ALK-ABELLÓ A/S

BRIEF-Alk-Abelló to issue shares in private placement

* ALK-ABELLÓ A/S TO ISSUE UP TO 92,076 AA SHARES AND UP TO 920,760 B SHARES IN A PRIVATE PLACEMENT Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Denmark's Alk Abello suspends dividend to support North America investment

Danish pharma company Alk Abello said on Monday it would invest 1 billion Danish crowns ($159 million) in its North America business, a move that is expected put a lid on earnings and revenue growth in the near term.

UPDATE 1-Denmark's Alk Abello suspends dividend to support North America investment

Dec 4 Danish pharma company Alk Abello said on Monday it would invest 1 billion Danish crowns ($159 million) in its North America business, a move that is expected put a lid on earnings and revenue growth in the near term.

Danish pharma company Alk Abello to invest 1 bln crowns in North America

Dec 4 Danish pharma company Alk Abello said on Monday it would invest about 1 billion Danish crowns ($159.5 million) over the next three years to develop its North America business and said it expected earnings to be subdued during this period.

BRIEF-ALK-Abello To Invest Around DKK 1 Bln In North America​

* ‍WILL INVEST APPROXIMATELY DKK 1 BILLION TO SUCCEED IN NORTH AMERICA​

BRIEF-ALK Reaches Agreement With Health Authorities In France

* ALK SECURES PRICING AND REIMBURSEMENT FOR ACARIZAX® IN FRANCE

Select another date: